• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咪唑并[1,2- a]吡啶封端的选择性 HDAC6 抑制剂的多组分合成及结合模式。

Multicomponent Synthesis and Binding Mode of Imidazo[1,2- a]pyridine-Capped Selective HDAC6 Inhibitors.

机构信息

Institut für Pharmazie , Universität Leipzig , Brüderstraße 34 , 04103 Leipzig , Germany.

Institut für Pharmazeutische und Medizinische Chemie , Heinrich-Heine-Universität Düsseldorf , Universitätsstr. 1 , 40225 Düsseldorf , Germany.

出版信息

Org Lett. 2018 Jun 1;20(11):3255-3258. doi: 10.1021/acs.orglett.8b01118. Epub 2018 May 23.

DOI:10.1021/acs.orglett.8b01118
PMID:29790770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5999327/
Abstract

The multicomponent synthesis of a mini-library of histone deacetylase inhibitors with imidazo[1,2- a]pyridine-based cap groups is presented. The biological evaluation led to the discovery of the hit compound MAIP-032 as a selective HDAC6 inhibitor with promising anticancer activity. The X-ray structure of catalytic domain 2 from Danio rerio HDAC6 complexed with MAIP-032 revealed a monodentate zinc-binding mode.

摘要

本文报道了一种基于咪唑并[1,2-a]吡啶的组蛋白去乙酰化酶抑制剂的小型文库的多组分合成。生物评价发现了先导化合物 MAIP-032,它是一种选择性 HDAC6 抑制剂,具有有前景的抗癌活性。与 MAIP-032 结合的斑马鱼 HDAC6 催化结构域 2 的 X 射线结构揭示了一种单价锌结合模式。

相似文献

1
Multicomponent Synthesis and Binding Mode of Imidazo[1,2- a]pyridine-Capped Selective HDAC6 Inhibitors.咪唑并[1,2- a]吡啶封端的选择性 HDAC6 抑制剂的多组分合成及结合模式。
Org Lett. 2018 Jun 1;20(11):3255-3258. doi: 10.1021/acs.orglett.8b01118. Epub 2018 May 23.
2
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.HDAC6 选择性羟肟酸抑制剂的不寻常锌结合模式。
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13459-13464. doi: 10.1073/pnas.1718823114. Epub 2017 Dec 4.
3
Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes.组蛋白去乙酰化酶6抑制剂复合物的表达、纯化及结晶方法。
Methods Enzymol. 2019;626:447-474. doi: 10.1016/bs.mie.2019.06.028. Epub 2019 Jul 18.
4
Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity.组蛋白去乙酰化酶 6 选择性抑制剂及封端基团对羟肟酸锌配位齿数的影响。
J Med Chem. 2018 Sep 13;61(17):8054-8060. doi: 10.1021/acs.jmedchem.8b01013. Epub 2018 Aug 17.
5
Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.抑制剂与组蛋白去乙酰化酶 6 结合的亲和力和选择性的结构决定因素。
Bioorg Med Chem Lett. 2020 Apr 15;30(8):127023. doi: 10.1016/j.bmcl.2020.127023. Epub 2020 Feb 11.
6
Synthesis and Biological Investigation of Phenothiazine-Based Benzhydroxamic Acids as Selective Histone Deacetylase 6 Inhibitors.基于吩噻嗪的苯甲羟肟酸的合成与生物研究作为选择性组蛋白去乙酰化酶 6 抑制剂。
J Med Chem. 2019 Feb 14;62(3):1138-1166. doi: 10.1021/acs.jmedchem.8b01090. Epub 2019 Feb 1.
7
Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.探究组蛋白去乙酰化酶 6 复合物中抑制剂亲和力和选择性的结构决定因素。
J Med Chem. 2020 Jan 9;63(1):295-308. doi: 10.1021/acs.jmedchem.9b01540. Epub 2019 Dec 19.
8
Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.抑制剂与组蛋白去乙酰化酶 6 神秘催化结构域 CD1 的活性位点突变体的结合。
Acta Crystallogr F Struct Biol Commun. 2020 Sep 1;76(Pt 9):428-437. doi: 10.1107/S2053230X20010250. Epub 2020 Aug 19.
9
Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties.格罗贝克-布勒克本-比尼亚梅介导的具有抗炎特性的选择性 HDAC6 抑制剂的多组分合成。
Bioorg Chem. 2024 Feb;143:107072. doi: 10.1016/j.bioorg.2023.107072. Epub 2024 Jan 2.
10
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups.多组分合成、结合模式及具有分叉封顶基团的选择性组蛋白去乙酰化酶 6(HDAC6)抑制剂的构效关系。
J Med Chem. 2020 Sep 24;63(18):10339-10351. doi: 10.1021/acs.jmedchem.9b01888. Epub 2020 Sep 1.

引用本文的文献

1
Development and Characterization of the First Selective Class IIb Histone Deacetylase Degraders.首个选择性IIb类组蛋白去乙酰化酶降解剂的研发与表征
J Med Chem. 2025 Jul 10;68(13):13793-13821. doi: 10.1021/acs.jmedchem.5c00674. Epub 2025 Jun 18.
2
Formaldehyde surrogates in multicomponent reactions.多组分反应中的甲醛替代物
Beilstein J Org Chem. 2025 Mar 13;21:564-595. doi: 10.3762/bjoc.21.45. eCollection 2025.
3
Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties.

本文引用的文献

1
Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.HDAC6 选择性羟肟酸抑制剂的不寻常锌结合模式。
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13459-13464. doi: 10.1073/pnas.1718823114. Epub 2017 Dec 4.
2
Design and Synthesis of Terephthalic Acid-Based Histone Deacetylase Inhibitors with Dual-Stage Anti-Plasmodium Activity.基于对苯二甲酸的组蛋白去乙酰化酶抑制剂的设计与合成及其两阶段抗疟原虫活性。
ChemMedChem. 2017 Oct 9;12(19):1627-1636. doi: 10.1002/cmdc.201700360. Epub 2017 Sep 13.
3
Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents.
探索组蛋白去乙酰化酶(HDAC)抑制剂中的替代锌结合基团发现,一种具有化学增敏特性的基于乙基肼的强效HDAC抑制剂。
J Med Chem. 2025 Feb 27;68(4):4426-4452. doi: 10.1021/acs.jmedchem.4c02373. Epub 2025 Feb 13.
4
The Groebke-Blackburn-Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019-2023).格罗布克-布莱克本-比内梅反应步入成熟:自其21岁生日(2019 - 2023年)以来的创新与改进
Beilstein J Org Chem. 2024 Aug 1;20:1839-1879. doi: 10.3762/bjoc.20.162. eCollection 2024.
5
Design, synthesis, molecular docking and anti-proliferative activity of novel phenothiazine containing imidazo[1,2-]pyridine derivatives against MARK4 protein.新型含吩噻嗪咪唑并[1,2 -]吡啶衍生物对MARK4蛋白的设计、合成、分子对接及抗增殖活性
RSC Med Chem. 2024 Apr 19;15(6):1942-1958. doi: 10.1039/d4md00059e. eCollection 2024 Jun 19.
6
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia.氟代肽基组蛋白去乙酰化酶(HDAC)抑制剂的开发用于治疗耐药性急性白血病。
J Med Chem. 2022 Nov 24;65(22):15457-15472. doi: 10.1021/acs.jmedchem.2c01418. Epub 2022 Nov 9.
7
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies.咪唑类化合物作为潜在的抗癌剂:近期研究进展综述。
Molecules. 2021 Jul 11;26(14):4213. doi: 10.3390/molecules26144213.
8
Unique Molecular Interaction with the Histone Deacetylase 6 Catalytic Tunnel: Crystallographic and Biological Characterization of a Model Chemotype.独特的分子与组蛋白去乙酰化酶 6 催化隧道相互作用:模型化学型的晶体学和生物学特征。
J Med Chem. 2021 Mar 11;64(5):2691-2704. doi: 10.1021/acs.jmedchem.0c01922. Epub 2021 Feb 12.
9
Spiroindoline-Capped Selective HDAC6 Inhibitors: Design, Synthesis, Structural Analysis, and Biological Evaluation.螺吲哚啉封端的选择性组蛋白去乙酰化酶6抑制剂:设计、合成、结构分析及生物学评价
ACS Med Chem Lett. 2020 Sep 29;11(11):2268-2276. doi: 10.1021/acsmedchemlett.0c00395. eCollection 2020 Nov 12.
10
Binding of inhibitors to active-site mutants of CD1, the enigmatic catalytic domain of histone deacetylase 6.抑制剂与组蛋白去乙酰化酶 6 神秘催化结构域 CD1 的活性位点突变体的结合。
Acta Crystallogr F Struct Biol Commun. 2020 Sep 1;76(Pt 9):428-437. doi: 10.1107/S2053230X20010250. Epub 2020 Aug 19.
噻唑并杂环 hHDAC6 抑制剂的探索作为潜在的抗疟药物。
Future Med Chem. 2017 Mar;9(4):357-364. doi: 10.4155/fmc-2016-0215. Epub 2017 Mar 6.
4
Novel histone deacetylase 6 (HDAC6) selective inhibitors: a patent evaluation (WO2014181137).新型组蛋白去乙酰化酶6(HDAC6)选择性抑制剂:专利评估(WO2014181137)
Expert Opin Ther Pat. 2017 Mar;27(3):229-236. doi: 10.1080/13543776.2017.1282945. Epub 2017 Jan 31.
5
Histone deacetylase 6 structure and molecular basis of catalysis and inhibition.组蛋白去乙酰化酶6的结构、催化及抑制作用的分子基础
Nat Chem Biol. 2016 Sep;12(9):741-7. doi: 10.1038/nchembio.2134. Epub 2016 Jul 25.
6
Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.结构洞察 HDAC6 微管脱乙酰酶及其选择性抑制。
Nat Chem Biol. 2016 Sep;12(9):748-54. doi: 10.1038/nchembio.2140. Epub 2016 Jul 25.
7
The world of protein acetylation.蛋白质乙酰化的世界。
Biochim Biophys Acta. 2016 Oct;1864(10):1372-401. doi: 10.1016/j.bbapap.2016.06.007. Epub 2016 Jun 11.
8
Rational design and diversity-oriented synthesis of peptoid-based selective HDAC6 inhibitors.基于类肽的选择性组蛋白去乙酰化酶6(HDAC6)抑制剂的合理设计与多样性导向合成
Chem Commun (Camb). 2016 Feb 21;52(15):3219-22. doi: 10.1039/c5cc10301k.
9
Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.在轴索性遗传性运动感觉神经病模型中具有增强活性的双环封端组蛋白去乙酰化酶6抑制剂。
ACS Chem Neurosci. 2016 Feb 17;7(2):240-58. doi: 10.1021/acschemneuro.5b00286. Epub 2015 Dec 7.
10
Groebke-Blackburn-Bienaymé multicomponent reaction: emerging chemistry for drug discovery.格罗布克-布莱克本-比内梅多组分反应:药物发现的新兴化学
Mol Divers. 2016 Feb;20(1):233-54. doi: 10.1007/s11030-015-9602-6. Epub 2015 May 28.